Mani

Basic Information

Stock Code
7730
Industry
Precision Instruments
Category Detail
Biotechnology & Pharmaceuticals
Prefecture
Tochigi Prefecture
Establishment Year
December 1959
Listing Year
June 2001
Official Website
http://www.mani.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
ABC-Mart, Hogy Medical, Create Medic, JMS, Nakanishi, Asahi Intecc, Medikit, Daiken Iki, Shofu, Nipro

Overview

Mani is a medical device manufacturer founded in 1959, specializing in precision suture needle production, and holds a high market share both domestically and internationally.

Current Situation

Mani recorded consolidated sales of approximately 28.5 billion yen and operating profit of approximately 8.4 billion yen for the fiscal year ending August 2024, maintaining solid business performance. Its mainstay surgical suture needles hold approximately 90% domestic market share and are exported to over 100 countries worldwide. Recently, it constructed a new factory in Takanezawa Town to accelerate the establishment of automated production technologies. Guided by its corporate philosophy of 'the world's best quality,' it conducts 'World's Best or Not' meetings twice a year to sustain product competitiveness. For environmental considerations, it is promoting renewable energy utilization at the new factory and actively pursuing sustainability initiatives. Moving forward, it aims to capitalize on the reshoring trend in domestic production, pursuing further technological innovation and overseas market expansion. It is investing in research and development to enhance precision in medical instruments and improve production efficiency.

Trivia

Interesting Facts

  • Approximately 90% domestic market share for surgical suture needles.
  • Original company name at founding was Matsutani Seisakusho.
  • World's first commercialization of stainless steel suture needles.
  • New factory built on site of former Kirin Beer Tochigi factory.
  • Holds 'World's Best or Not' meetings twice a year for quality control.
  • Wire is raw material, with material cost ratio under 1%, very low cost.
  • Introduced high-precision automated production equipment in Takanezawa Town, Tochigi Prefecture.
  • Exports products to over 100 countries, an international company.
  • In addition to medical devices, offers dental reamers and files.
  • Continues global growth while rooted in the local community.

Hidden Connections

  • Utilizes former Kirin Beer Tochigi factory site to support regional revitalization.
  • Deep ties with major shareholder Manix Co., Ltd.
  • Featured on Nikkei Special 'Cambria Palace,' gaining attention.
  • Intense market competition with related company and rival Asahi Intecc.
  • Significant contributions to local economy through factories in regions.
  • Collaborates with numerous medical device manufacturers on parts supply.
  • Low material ratio contributes to competitive advantage.
  • Recognized as niche top player in surgical suture needle industry.

Future Outlook

Growth Drivers

  • Improved production efficiency through automated production technology
  • Expansion of medical device demand in overseas markets
  • Technological innovation in high-precision medical instruments development
  • Tailwinds from reshoring of domestic medical device production
  • Enhanced environmental value through renewable energy utilization
  • Improved responsiveness to diverse medical needs
  • Increased medical device demand due to aging society
  • Strengthened product competitiveness through new materials
  • Advancement of digital traceability systems
  • Strengthened brand trust through locally rooted management
  • Market adaptability through compliance with medical safety standards
  • Promotion of sustainable production and environmental management

Strategic Goals

  • Maintain and expand top domestic industry market share
  • Achieve over 40% overseas sales ratio
  • 50% reduction in greenhouse gas emissions
  • Expansion of fully automated production lines
  • Revenue growth through high value-added medical instruments
  • Establish customer-centric innovation in product development
  • Strengthen coexistence with local communities and environmental protection activities
  • Company-wide implementation of advanced quality assurance and traceability
  • Active entry into next-generation medical device markets
  • Medium- to long-term talent development and diversity-focused organization building

Business Segments

Medical Device Manufacturing Support

Overview
Supports manufacturing and supply of high-precision instruments for medical settings.
Competitiveness
High-quality manufacturing technology with low material costs
Customers
  • Medical Device Manufacturers
  • Hospital Equipment Suppliers
  • Medical Institutions
  • Pharmaceutical Companies
Products
  • Surgical Suture Needles
  • Dental Reamer Files
  • Medical Device Accessories

Overseas Export Business

Overview
Exports medical devices to over 100 countries worldwide for global expansion.
Competitiveness
Highly regarded brand power in overseas markets
Customers
  • Overseas Medical Institutions
  • International Medical Device Distributors
Products
  • Suture Needles
  • Dental Medical Devices

R&D Support

Overview
Provides technical support contributing to the development of cutting-edge medical devices.
Competitiveness
Precision machining technology and proprietary material development
Customers
  • University Research Institutions
  • Medical Device Laboratories
  • Development Ventures
Products
  • Special Medical Needles
  • Precision Machined Parts

Competitive Advantage

Strengths

  • High market share in domestic suture needle market
  • Advanced precision processing technology
  • Stable raw material procurement costs
  • Continuous technological innovation framework
  • Robust quality control system
  • Long years of medical device manufacturing experience
  • Trusted medical brand
  • Expansion into international markets
  • Proprietary product development capabilities
  • High-efficiency production line technology
  • Strong collaboration with medical sites
  • Locally rooted corporate structure
  • Product durability and reliability
  • Solid financial foundation
  • Abundant patented technologies

Competitive Advantages

  • Industry-leading suture needle quality maintenance
  • Cost competitiveness with low material ratios
  • Export network to over 100 countries worldwide
  • Trusted brand among medical institutions domestically and internationally
  • Expertise and experience in precision instrument manufacturing
  • Production efficiency from automation technology at new factory
  • Product quality maintenance through unique quality evaluation meetings
  • Renewable energy utilization for environmental compliance
  • Rapid response to needs from medical sites
  • Precise niche market strategy operation
  • Cost optimization through factory placement in regions
  • High employee technical skills and expertise
  • Global expansion with diverse customer base
  • Product innovation through high R&D investment
  • Swift response to medical-related regulations

Threats

  • Low-price strategies from overseas competitors
  • Demand fluctuations due to changes in healthcare systems
  • Raw material price volatility risks
  • Market lag from delays in technological innovation
  • Export restriction risks from international situations
  • Cost increases from strengthened regulations
  • Changes in entry barriers to emerging markets
  • Profit pressure from exchange rate fluctuations
  • Supply chain disruptions from natural disasters
  • Intensifying talent acquisition competition
  • Stricter medical device safety standards
  • Global economic uncertainty

Innovations

2024: Introduction of Automated Production Technology at Takanezawa New Factory

Overview
Fully adopts automated production lines, significantly improving production efficiency and quality control.
Impact
Achieved 30% increase in production capacity and cost reductions

2023: Development of Biocompatible Suture Needles

Overview
Developed new products using highly body-compatible materials, enhancing safety in medical settings.
Impact
Successfully expanded market share and acquired new customers

2022: Enhanced Introduction of Renewable Energy

Overview
Installed solar and wind power facilities at new factory, contributing to reduced environmental impact.
Impact
20% reduction in CO2 emissions

2021: Construction of Product Traceability System

Overview
Promoted digital management of manufacturing processes to strengthen quality assurance.
Impact
15% reduction in product defect rate

2020: Advanced Precision Cutting Technology

Overview
Introduced cutting processing technology compatible with new materials, enabling diverse product designs.
Impact
Expanded product portfolio and market reach

Sustainability

  • Expansion of renewable energy utilization at new factory
  • Strengthened energy-saving measures in production processes
  • Waste recycling rate improvement program
  • Product design considering reduced environmental impact
  • Cooperation with local communities on environmental conservation activities
  • Employee environmental education and awareness enhancement
  • Initiatives for sustainable resource use
  • Proper handling and management of medical waste
  • Establishment of green procurement standards
  • Setting targets for greenhouse gas emission reductions
  • Safety and health management and workplace environment improvements
  • Regular issuance of social responsibility reports